M Bosiers

Summary

Country: Belgium

Publications

  1. ncbi request reprint Belgian experience with FilterWire EX in the prevention of embolic events during carotid stenting
    Marc Bosiers
    Department of Vascular Surgery, AZ St Blasius, Dendermonde
    J Endovasc Ther 10:695-701. 2003
  2. ncbi request reprint Use of StarClose for brachial artery closure after percutaneous endovascular interventions
    Alessandra Puggioni
    Department of Vascular Surgery, AZ St Blasius, Dendermonde, Belgium
    Vascular 16:85-90. 2008
  3. ncbi request reprint Selection of treatment for patients with carotid artery disease: medication, carotid endarterectomy, or carotid artery stenting
    Marc Bosiers
    Department of Vascular Surgery, AZ St Blasius, Dendermonde, Belgium
    Vascular 13:92-7. 2005
  4. ncbi request reprint Excimer laser assisted angioplasty for critical limb ischemia: results of the LACI Belgium Study
    M Bosiers
    Department of Vascular Surgery, AZ St Blasius, 9200 Dendermonde, Belgium
    Eur J Vasc Endovasc Surg 29:613-9. 2005
  5. ncbi request reprint Carotid artery stenting: which stent for which lesion?
    Marc Bosiers
    Department of Vascular Surgery, AZ St Blasius, Dendermonde, Belgium
    Vascular 13:205-10. 2005
  6. ncbi request reprint The use of the cryoplasty technique in the treatment of infrapopliteal lesions for Critical Limb Ischemia patients in a routine hospital setting: one-year outcome of the Cryoplasty CLIMB Registry
    M Bosiers
    Department of Vascular Surgery, AZ St Blasius Dendermonde, Belgium
    J Cardiovasc Surg (Torino) 51:193-202. 2010
  7. ncbi request reprint Are there predictive risk factors for complications after carotid artery stenting?
    M Bosiers
    Department of Vascular Surgery, AZ St Blasius, Dendermonde, Belgium
    J Cardiovasc Surg (Torino) 48:125-30. 2007
  8. ncbi request reprint BRAVISSIMO: 12-month results from a large scale prospective trial
    M Bosiers
    AZ Sint Blasius, Dendermonde, Belgium
    J Cardiovasc Surg (Torino) 54:235-53. 2013
  9. ncbi request reprint Drug-eluting technologies in femoral artery lesions
    K Deloose
    Departement Vascular Surgery, A Z Sint Blasius, Dendermonde, Belgium
    J Cardiovasc Surg (Torino) 54:217-24. 2013
  10. ncbi request reprint Refining stent technologies for femoral interventions
    M Bosiers
    Department Vascular Surgery, A Z Sint Blasius, Dendermonde, Belgium
    J Cardiovasc Surg (Torino) 53:465-73. 2012

Collaborators

Detail Information

Publications53

  1. ncbi request reprint Belgian experience with FilterWire EX in the prevention of embolic events during carotid stenting
    Marc Bosiers
    Department of Vascular Surgery, AZ St Blasius, Dendermonde
    J Endovasc Ther 10:695-701. 2003
    ..To evaluate the performance of the FilterWire EX for the capture and removal of debris and prevention of embolic events during endovascular carotid interventions...
  2. ncbi request reprint Use of StarClose for brachial artery closure after percutaneous endovascular interventions
    Alessandra Puggioni
    Department of Vascular Surgery, AZ St Blasius, Dendermonde, Belgium
    Vascular 16:85-90. 2008
    ..StarClose is safe and effective in providing hemostasis following interventional procedures through the brachial artery; further advantages include patients comfort and early discharge...
  3. ncbi request reprint Selection of treatment for patients with carotid artery disease: medication, carotid endarterectomy, or carotid artery stenting
    Marc Bosiers
    Department of Vascular Surgery, AZ St Blasius, Dendermonde, Belgium
    Vascular 13:92-7. 2005
    ..7% in asymptomatic patients and 2.6% in symptomatic patients. After CEA, these rates were 0% and 3.3%, respectively. Careful selection of treatment modality according to predetermined criteria can result in improved outcomes...
  4. ncbi request reprint Excimer laser assisted angioplasty for critical limb ischemia: results of the LACI Belgium Study
    M Bosiers
    Department of Vascular Surgery, AZ St Blasius, 9200 Dendermonde, Belgium
    Eur J Vasc Endovasc Surg 29:613-9. 2005
    ....
  5. ncbi request reprint Carotid artery stenting: which stent for which lesion?
    Marc Bosiers
    Department of Vascular Surgery, AZ St Blasius, Dendermonde, Belgium
    Vascular 13:205-10. 2005
    ....
  6. ncbi request reprint The use of the cryoplasty technique in the treatment of infrapopliteal lesions for Critical Limb Ischemia patients in a routine hospital setting: one-year outcome of the Cryoplasty CLIMB Registry
    M Bosiers
    Department of Vascular Surgery, AZ St Blasius Dendermonde, Belgium
    J Cardiovasc Surg (Torino) 51:193-202. 2010
    ..It was the objective of the Cryoplasty CLIMB to evaluate the effectiveness of the PolarCath device in a standard clinical practice in the treatment of infrapopliteal lesions in critical limb ischemia patients...
  7. ncbi request reprint Are there predictive risk factors for complications after carotid artery stenting?
    M Bosiers
    Department of Vascular Surgery, AZ St Blasius, Dendermonde, Belgium
    J Cardiovasc Surg (Torino) 48:125-30. 2007
    ..The aim of this study was to identify predictive risk factors for complications during and after carotid artery stenting (CAS)...
  8. ncbi request reprint BRAVISSIMO: 12-month results from a large scale prospective trial
    M Bosiers
    AZ Sint Blasius, Dendermonde, Belgium
    J Cardiovasc Surg (Torino) 54:235-53. 2013
    ..We notice similar endovascular results compared to surgery, however without the invasive character of surgery...
  9. ncbi request reprint Drug-eluting technologies in femoral artery lesions
    K Deloose
    Departement Vascular Surgery, A Z Sint Blasius, Dendermonde, Belgium
    J Cardiovasc Surg (Torino) 54:217-24. 2013
    ..The transfer to the peripheral area is nowadays ongoing. Which technique and device for which lesion and patient requires further investigation to build up a real evidence based SFA treatment strategy...
  10. ncbi request reprint Refining stent technologies for femoral interventions
    M Bosiers
    Department Vascular Surgery, A Z Sint Blasius, Dendermonde, Belgium
    J Cardiovasc Surg (Torino) 53:465-73. 2012
    ..Further investigations in this area will eventually evolve in the creation of a superior endovascular treatment modality with high long-term patency rates and minimal detriments...
  11. ncbi request reprint BRAVISSIMO study: 12-month results from the TASC A/B subgroup
    M Bosiers
    Department Vascular Surgery, A Z Sint Blasius, Dendermonde, Belgium
    J Cardiovasc Surg (Torino) 53:91-9. 2012
    ..0) and without Target Lesion Revascularization (TLR) within 12 months...
  12. ncbi request reprint Does free cell area influence the outcome in carotid artery stenting?
    M Bosiers
    Department of Vascular Surgery, AZ St Blasius, Dendermonde, Belgium
    Eur J Vasc Endovasc Surg 33:135-41; discussion 142-3. 2007
    ..To identify if carotid stent design, especially free cell area, impacts on the 30-day rates for stroke, death and TIA after carotid artery stenting (CAS)...
  13. ncbi request reprint Endovascular management of acute limb ischemia
    P Peeters
    Department of Cardiovascular and Thoracic Surgery, Imelda Hospital, Bonheiden, Belgium2 Department of Vascular Surgery, AZ St Blasius, Dendermonde, Belgium
    J Cardiovasc Surg (Torino) 51:329-36. 2010
    ..Therefore, we believe thrombolytic therapy should be a part of the vascular surgeon's armamentarium to safely and successfully treat ALI patients...
  14. ncbi request reprint Prevention and treatment of in-stent restenosis
    M Bosiers
    Department of Vascular Surgery, AZ St Blasius, Dendermonde, Belgium
    J Cardiovasc Surg (Torino) 51:591-8. 2010
    ..However, the continuing search for better solutions and the technological evolution lead to the introduction of the Viabahn with PROPATEN coating, DES and DCB, which may result in the first promising treatment options for ISR...
  15. ncbi request reprint Update management below knee intervention
    M Bosiers
    Department of Vascular Surgery, AZ St Blasius, Dendermonde, Belgium
    Minerva Cardioangiol 57:117-29. 2009
    ....
  16. ncbi request reprint Are drug-eluting stents the future of SFA treatment?
    M Bosiers
    Department of Vascular Surgery, AZ St Blasius, Dendermonde, Belgium
    J Cardiovasc Surg (Torino) 51:115-9. 2010
    ....
  17. ncbi request reprint In lower extremity PTAs intraluminal is better than subintimal
    M Bosiers
    Department of Vascular Surgery, AZ Sint Blasius, Dendermonde, Belgium
    J Cardiovasc Surg (Torino) 53:223-7. 2012
    ..A wide variety of devices designed to obtain intraluminal lesion passage is available and is currently being used in vascular centers worldwide. With intraluminal techniques, success rates of up to 95% have been reported...
  18. ncbi request reprint Present and future of endovascular SFA treatment: stents, stent-grafts, drug coated balloons and drug coated stents
    M Bosiers
    Department of Vascular Surgery, AZ St Blasius, Dendermonde, Belgium
    J Cardiovasc Surg (Torino) 49:159-65. 2008
    ..g. active coatings) towards peripheral devices might broaden the indications for the minimal invasive strategy towards TransAtlantic Inter-Society Consensus (TASC) II C&D lesions...
  19. doi request reprint What practical factors guide the choice of stent and protection device during carotid angioplasty?
    M Bosiers
    Department of Vascular Surgery, AZ St Blasius, Dendermonde, Belgium
    Eur J Vasc Endovasc Surg 35:637-43. 2008
    ..But certainly, personal preferences and familiarity with a specific device may legitimately influence the decision to choose one over another...
  20. ncbi request reprint The role of carotid artery stenting for recent cerebral ischemia
    M Bosiers
    Department Vascular Surgery, A Z Sint Blasius, Dendermonde, Belgium
    J Cardiovasc Surg (Torino) 51:293-304. 2010
    ..The encouraging preliminary results await confirmation from prospective, randomized studies...
  21. ncbi request reprint Drug-eluting stents below the knee
    M Bosiers
    Department of Vascular Surgery, A Z Sint Blasius, Dendermonde, Belgium
    J Cardiovasc Surg (Torino) 52:231-4. 2011
    ..This makes that primary DES placement can be recommended as treatment strategy in short BTK-lesions...
  22. ncbi request reprint Nitinol stenting for treatment of ''below-the-knee'' critical limb ischemia: 1-year angiographic outcome after Xpert stent implantation
    M Bosiers
    Department of Vascular Surgery, AZ St Blasius, Kroonveldlaan 50, 9200 Dendermonde, Belgium
    J Cardiovasc Surg (Torino) 48:455-61. 2007
    ..We investigated the efficacy of Xpert (Abbott Vascular Devices) nitinol stents for the treatment of infrapopliteal lesions in patients with critical limb ischemia (CLI)...
  23. ncbi request reprint Will absorbable metal stent technology change our practice?
    M Bosiers
    Department of Vascular Surgery, AZ St Blasius, Dendermonde, Belgium
    J Cardiovasc Surg (Torino) 47:393-7. 2006
    ..This removes a potential trigger for late restenosis...
  24. ncbi request reprint The Zilver® PTX® Single Arm Study: 12-month results from the TASC C/D lesion subgroup
    M Bosiers
    Department of Vascular Surgery, AZ St Blasius, Dendermonde, Belgium
    J Cardiovasc Surg (Torino) 54:115-22. 2013
    ..The aim of the present article was to report the 12-month results of the Zilver® PTX® Single Arm StudyTASC C/D de novo lesion subgroup...
  25. ncbi request reprint Carotid endovascular interventions: patient selection, devices, techniques and tips
    M Bosiers
    Department of Vascular Surgery, AZ St Blasius, Dendermonde, Belgium
    Minerva Cardioangiol 58:97-111. 2010
    ..This article reviews the principles of patient selection and device selection in contemporary CAS practice...
  26. ncbi request reprint Percutaneous transluminal angioplasty for treatment of ''below-the-knee'' critical limb ischemia: early outcomes following the use of sirolimus-eluting stents
    M Bosiers
    Department of Vascular Surgery, AZ St Blasius, Dendermonde, Belgium
    J Cardiovasc Surg (Torino) 47:171-6. 2006
    ..We investigated the safety and efficacy of sirolimus-eluting stents in the treatment of patients with severe below-the-knee' critical limb ischemia...
  27. ncbi request reprint Flemish experience using the Advanta V12 stent-graft for the treatment of iliac artery occlusive disease
    M Bosiers
    Department of Vascular Surgery, AZ St Blasius, Dendermonde, Belgium
    J Cardiovasc Surg (Torino) 48:7-12. 2007
    ..Additionally, the primary patency and clinical and hemodynamic efficacy at 1 year were analysed...
  28. ncbi request reprint Review of stents for the carotid artery
    M Bosiers
    Department of Vascular Surgery, AZ St Blasius Dendermonde, Belgium
    J Cardiovasc Surg (Torino) 47:107-13. 2006
    ....
  29. pmc AMS INSIGHT--absorbable metal stent implantation for treatment of below-the-knee critical limb ischemia: 6-month analysis
    Marc Bosiers
    Department of Vascular Surgery, AZ St Blasius, Kroonveldlaan 50, 9200, Dendermonde, Belgium
    Cardiovasc Intervent Radiol 32:424-35. 2009
    ..0%). Although the present study indicates that the AMS technology can be safely applied, it did not demonstrate efficacy in long-term patency over standard PTA in the infrapopliteal vessels...
  30. ncbi request reprint Does carotid artery stenting work on the long run: 5-year results in high-volume centers (ELOCAS Registry)
    M Bosiers
    Department of Vascular Surgery, AZ St Blasius, Dendermonde, Belgium
    J Cardiovasc Surg (Torino) 46:241-7. 2005
    ..We report CAS data up to 5 years, both late stroke rate and patency rates as observed in 4 high-volume European centers...
  31. ncbi request reprint Importance of exchange of vascular trainees among centers
    M Bosiers
    Department of Vascular Surgery AZ Sint Blasius, Dendermonde, East Flanders, Belgium
    J Cardiovasc Surg (Torino) 52:39-46. 2011
    ..The development of a core-curriculum and mutual recognition of training centers is urgently needed and further steps in the harmonization of training programs and requirements need to be stimulated...
  32. ncbi request reprint The type of embolic protection does not influence the outcome in carotid artery stenting
    Vikram Iyer
    Department of Vascular Surgery, AZ St Blasius, Dendermonde, Belgium
    J Vasc Surg 46:251-6. 2007
    ..Specifically, we aimed to verify their clinical effectiveness and to compare clinical outcomes between specific devices and types of EPDs...
  33. doi request reprint The impact of embolic protection device and stent design on the outcome of CAS
    Marc Bosiers
    Department of Vascular Surgery, AZ St Blasius, Dendermonde, Belgium
    Perspect Vasc Surg Endovasc Ther 20:272-9. 2008
    ..But certainly, personal preferences and familiarity with a specific device may legitimately influence the decision to choose one over another...
  34. ncbi request reprint Do device characteristics impact outcome in carotid artery stenting?
    Joseph P Hart
    Department of Vascular Surgery, AZ St Blasius, Dendermonde, Belgium
    J Vasc Surg 44:725-30; discussion 730-1. 2006
    ....
  35. ncbi request reprint Heparin-bonded expanded polytetrafluoroethylene vascular graft for femoropopliteal and femorocrural bypass grafting: 1-year results
    Marc Bosiers
    Department of Vascular Surgery, St Blasius Hospital, Dendermonde, Belgium
    J Vasc Surg 43:313-8; discussion 318-9. 2006
    ..This study assessed the performance of a new heparin-bonded ePTFE vascular graft that was designed to provide resistance to thrombosis and thereby decrease early graft failures and possibly prolong patency...
  36. ncbi request reprint One year outcome after primary stenting of infrapopliteal lesions with the Chromis Deep stent in the management of critical limb ischaemia
    Koen Deloose
    Department of Vascular Surgery, AZ St Blasius, Dendermonde, Belgium
    EuroIntervention 5:318-24. 2009
    ..The study investigates the safety and efficacy of primary stenting of infrapopliteal lesions using the Chromis Deep stent (Invatec, Roncadelle, Italy) in patients presenting with critical limb ischaemia (CLI)...
  37. doi request reprint Femoral bifurcation disease: balloon or knife
    Marc Bosiers
    AZ Sint Blasius, Kroonveldlaan 50, 9200 Dendermonde, Belgium
    Catheter Cardiovasc Interv 74:627-33. 2009
    ..If feasible, the hybrid approach with endarterectomy at the level of the bifurcation and endovascular repair of the inflow and outflow lesions is preferred in patients with multilevel disease...
  38. ncbi request reprint Use of the AngioSculpt scoring balloon for infrapopliteal lesions in patients with critical limb ischemia: 1-year outcome
    Marc Bosiers
    Department of Vascular Surgery, AZ St Blasius
    Vascular 17:29-35. 2009
    ..However, more patients, a longer follow-up, and randomized studies comparing it with conventional balloon angioplasty and stenting in the infrapopliteal region are required...
  39. ncbi request reprint Two-year outcome after Xpert stent implantation for treating below the knee lesions in critical limb ischemia
    Marc Bosiers
    Department of Vascular Surgery, AZ St Blasius, Dendermonde, Belgium
    Vascular 17:1-8. 2009
    ..Our results suggest that treatment with nitinol Xpert stents can be considered effective for treating CLI patients, with satisfying patency outcome...
  40. doi request reprint Nitinol stent implantation in long superficial femoral artery lesions: 12-month results of the DURABILITY I study
    Marc Bosiers
    Department of Vascular Surgery, AZ St Blasius, Dendermonde, Belgium
    J Endovasc Ther 16:261-9. 2009
    ..To evaluate the long-term efficacy and integrity of the PROTEGE EverFlex stent in superficial femoral artery (SFA) lesions in symptomatic patients with peripheral artery disease (PAD)...
  41. pmc Drug-eluting stents in the management of peripheral arterial disease
    Marc Bosiers
    Department of Vascular Surgery, AZ St Blasius Dendermonde, Belgium
    Vasc Health Risk Manag 4:553-9. 2008
    ....
  42. ncbi request reprint Preliminary results after application of absorbable metal stents in patients with critical limb ischemia
    Patrick Peeters
    Department of Cardiovascular and Thoracic Surgery, Imelda Hospital, 9820 Bonheiden, Belgium
    J Endovasc Ther 12:1-5. 2005
    ..To report the preliminary 3-month follow-up of a recently developed absorbable metal stent (AMS) for treatment of infrapopliteal lesions in patients with critical limb ischemia (CLI)...
  43. ncbi request reprint Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST)
    Hans Krankenberg
    Hamburg University Cardiovascular Center, Hamburg, Germany
    Circulation 116:285-92. 2007
    ..The present study was designed to investigate the impact of nitinol stenting of superficial femoral artery lesions with a maximum length of 10 cm on restenosis and clinical outcomes at 1 year...
  44. ncbi request reprint PTFE-covered self-expanding nitinol stents for the treatment of severe iliac and femoral artery stenoses and occlusions: final results from a prospective study
    Benjamin Wiesinger
    Division of Diagnostic Radiology, Department of Radiology, University of Tubingen, Germany
    J Endovasc Ther 12:240-6. 2005
    ..To evaluate the technical performance, safety, and 1-year clinical efficacy of polytetrafluoroethylene (PTFE)-covered nitinol stents in the treatment of atherosclerotic iliac and superficial femoral artery (SFA) disease...
  45. ncbi request reprint The capture of visible debris by distal cerebral protection filters during carotid artery stenting: Is it predictable?
    L Richard Sprouse
    Division of Vascular Surgery, Eastern Virginia Medical School, Norfolk, VA, USA
    J Vasc Surg 41:950-5. 2005
    ..The current study was undertaken to identify the clinical factors predictive for the presence or absence of visible debris captured by distal filter devices during CAS...
  46. ncbi request reprint Endovascular therapy as the primary approach for limb salvage in patients with critical limb ischemia: experience with 443 infrapopliteal procedures
    Marc Bosiers
    Department of Cardiovascular and Thoracic Surgery, Imelda Hospital, Bonheiden, Belgium
    Vascular 14:63-9. 2006
    ..Prospective, randomized, multicenter trials will be needed to further establish the role of endovascular intervention in this challenging patient group...
  47. ncbi request reprint Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial
    Stephan H Duda
    Center for Diagnostic Radiology and Minimally Invasive Therapy, The Jewish Hospital Berlin, Heinz Galinski Strasse 1, 13347 Berlin, Germany
    J Endovasc Ther 13:701-10. 2006
    ..To review clinical outcomes of patients with chronic limb ischemia and TASC type C lesions treated with sirolimus-eluting versus bare SMART nitinol self-expanding stents...
  48. ncbi request reprint What we learned about trials from the European Carotid Stent Trials
    Clark J Zeebregts
    Department of Surgery, University Medical Center Groningen, Groningen, The Netherlands
    Ann Vasc Surg 22:159-61. 2008
  49. ncbi request reprint Results of the multicenter first-in-man study of a novel scoring balloon catheter for the treatment of infra-popliteal peripheral arterial disease
    Dierk Scheinert
    Department of Angiology, Leipzig Heart Center, Leipzig, Germany
    Catheter Cardiovasc Interv 70:1034-9. 2007
    ..To evaluate the AngioSculpt (ASC), a novel scoring balloon catheter designed to treat complex diffuse fibro-calcific atherosclerotic lesions and avoid device slippage during deployment, in patients with infra-popliteal disease...
  50. doi request reprint The VenaTech LP permanent caval filter: effectiveness and safety in the prevention of pulmonary embolism--a European multicenter study
    Alain F Le Blanche
    Diagnostic and Interventional Woman s, Child s and Emergency Imaging Center, Hopital Nord, Universite de Picardie Jules Verne, Amiens, France
    J Vasc Interv Radiol 19:509-15. 2008
    ..To evaluate (i) the appropriateness, safety, and patient outcomes after placement of the VenaTech LP caval filter and (ii) the success of filter insertion through various venous access routes...
  51. ncbi request reprint Two different studies on carotid stent cell design importance, or are we just saying the same thing?
    Carlo Setacci
    Stroke 39:e129; author reply e133. 2008
  52. ncbi request reprint Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial
    Stephan H Duda
    Center for Diagnostic Radiology and Minimally Invasive Therapy, The Jewish Hospital Berlin, Heinz Galinski Str 1, 13347 Berlin, Germany
    J Vasc Interv Radiol 16:331-8. 2005
    ..To investigate further the safety and efficacy of the sirolimus-eluting S. M.A.R.T. Nitinol Self-expanding Stent by comparison with a bare stent in superficial femoral artery (SFA) obstructions...
  53. ncbi request reprint Drug-eluting bioabsorbable magnesium stent
    Carlo Di Mario
    Royal Brompton Hospital, London, UK
    J Interv Cardiol 17:391-5. 2004
    ....